> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Listing of Recent OMB-approved Information Collections
- URL: https://www.fdaweb.com/listing-of-recent-omb-approved-information-collections/
- Published: 2018-06-11T12:00:00.000Z
- Updated: 2026-09-15T00:12:19.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141655

*Federal Register* notice: FDA has published the following list of recent OMB-approved information collections:

- Biological Products—General Records and Postmarket Adverse Experience Reporting
- Guidance for Industry: Fast Track, Drug Development Programs—Designation, Development, and Application Review
- Export Certificates for FDA Regulated Products under U.S.C. Sections 801(e) and 802
- Content and Format of Labeling for Human Prescription Drugs and Biologics; Requirements for Pregnancy and Lactation Labeling
- Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics
- Guidance of Industry: Expedited Programs for Serious Conditions—Drugs and Biologics
- Evaluation of the Food and Drug Administration’s Point-of-Sale Campaign

To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-06-08/pdf/2018-12338.pdf?ref=fdaweb.com).